HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302

Known as: MM-302 
An antibody-targeted lipidic nano-carrier containing the antineoplastic anthracycline antibiotic doxorubicin encapsulated within liposomes, and… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2017
02420132017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Purpose: Therapeutic nanoparticles are designed to deliver their drug payloads through enhanced permeability and retention (EPR… (More)
Is this relevant?
2016
2016
Trastuzumab is the standard of care for HER2-positive breast cancer patients, markedly improving disease-free and overall… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is a particularly aggressive form of the disease, and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2016
Review
2016
The natural history of HER2-positive breast cancer has progressively improved since the introduction of the first anti-HER2… (More)
Is this relevant?
2015
2015
Effective drug delivery to tumors is a barrier to treatment with nanomedicines. Non-invasively tracking liposome biodistribution… (More)
Is this relevant?
2015
2015
Given the bulky nature of nanotherapeutics relative to small molecules, it is hypothesized that effective tumor delivery and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
BACKGROUND Features of the tumor microenvironment influence the efficacy of cancer nanotherapeutics. The ability to directly… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2013
2013
The studies described herein assess the potential of combining platinum-based chemotherapy with high-linear energy transfer (LET… (More)
Is this relevant?